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Abstract The increasing use of zinc oxide (ZnO) nano-
particles in sunscreens and other cosmetic products
demands a risk assessment that has to be done in toxico-
logical studies. Such investigations require profound
knowledge of the behavior of ZnO in cell culture media.
The current study was performed to get well-dispersed
suspensions of a hydrophilic (ZnO-hydro) and a lipophilic
coated (ZnO-lipo) ZnO nanomaterial for use in in vitro
tests. Therefore, systematic tests were carried out with
common dispersants (phosphate, lecithin, proteins) to elu-
cidate chemical and physical changes of ZnO nanoparticles
in water and physiological solutions (PBS, DMEM). Non-
physiological stock suspensions were prepared using
ultrasonication. Time-dependent changes of pH, conduc-
tivity, zeta potential, particle size and dissolution were
recorded. Secondly, the stock suspensions were added to
physiological media with or without albumin (BSA) or
serum (FBS), to examine characteristics such as agglom-
eration and dissolution. Stable stock suspensions were
obtained using phosphate as natural and physiological
electrostatic stabilizing agent. Lecithin proved to be an
effective wetting agent for ZnO-lipo. Although the particle
size remained constant, the suspension changed over time.
The pH increased as a result of ZnO dissolution and for-
mation of zinc phosphate complexes. The behavior of ZnO
in physiological media was found to depend strongly on the
additives used. Applying only phosphate as additive, ZnO-
hydro agglomerated within minutes. In the presence of
lecithin or BSA/serum, agglomeration was inhibited. ZnO
dissolution was higher under physiological conditions than
in the stock suspension. Serum especially promoted this
process. Using body-related dispersants (phosphate, leci-
thin) non-agglomerating stock suspensions of hydrophilic
and lipophilic ZnO were prepared as a prerequisite to
perform meaningful toxicological investigation. Both
nanomaterials showed a non-negligible dissolution behav-
ior that strongly depended on the surrounding conditions.
Agglomeration of ZnO particles in physiological media is a
complex function of particle coating, used dispersants and
serum proteins if supplemented. The present study gives a
clear guideline how to prepare and handle suspensions with
ZnO for in vitro testing and allows the correlation between
the chemical-physical particles behavior with findings from
toxicological tests.
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Background
Zinc oxide (ZnO) and titanium dioxide (TiO2) have
intrinsic UV-absorbing properties and are therefore used as
ingredients in sunscreens. Moreover, ZnO absorbs UV
radiation more effectively than TiO2 does, particularly in
the UVA range. With a sufficiently small particle size, ZnO
can absorb and scatter UV radiation, making sunscreens
transparent. Potential for human exposure to ZnO exists in
the workplace and in the private sphere. ZnO nanoparticles
can also be released in the environment by the production
process or usage by consumers. Therefore, a thorough risk
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assessment at each stage from production to use of the
product and disposal of ZnO is indispensable [1].
The changed chemical and physical parameters of
nanoparticles can lead to increased biological activity and
thus trigger unexpected reactions with biological systems.
One related question is whether nanoparticles are more
toxic than their larger counterparts [2, 3]. Hsiao and Huang
[4], for example, were able to demonstrate that the cyto-
toxicity of ZnO is size-dependent. In contrast, Lin et al. [5]
examined the differences between nanoscale and sub-
micron zinc oxides (70 and 420 nm) in human lung epi-
thelial cells (A549) and found nearly identical EC50 values
of 13.6 and 14.2 lg/ml. Despite different primary particle
sizes, the same hydrodynamic diameter for both of the ZnO
types were measured in cell culture media. Whether this is
a cause of the same toxicity or not, is not explained in more
detail. A second aspect of Lin’s study was to determine the
influence of free zinc ions. At Zn2? concentrations of
2–8 lg/ml, no significant cytotoxicity compared with a
blank test was found in their study. According to Lin, the
free zinc ions are not responsible for the toxicity of ZnO.
Hence, the dissolution of ZnO is a second aspect discussed
in relation with the toxicity of these particles. Contrary to
Lin’s study, Xia et al. [6] demonstrated that dissolution can
play an important role in cytotoxicity. The ZnO dissocia-
tion disrupts cellular zinc hemostasis, leading to lysosomal
and mitochondrial disruption, and finally cell death. In
Xia’s experiments, a maximum dissolved zinc concentra-
tion of 225 lM (corresponding to 14.7 lg/ml Zn2?) in
DMEM supplemented with FBS was noticed. Pujalte´ and
coworkers [7] hypothesized that ROS production, oxidative
stress, and cytotoxicity induced by ZnO NPs are partly
linked to the release of Zn2? ions. Their experiments were
performed in RPMI 1640 media without serum. It should
be noted here that particles show different behavior in
media with serum. Brunner et al. [8] also stated that the
toxic effect of ZnO could be attributed to the release of
Zn2? ions. They found a sharp concentration dependence
of the cytotoxic effects based on a critical Zn2? concen-
tration in the cell culture medium. All cells died above a
ZnO concentration of 15 ppm. Moreover, the presence or
absence of serum in in vitro experiments with ZnO
nanomaterials influences proliferation and genotoxicity [9].
The extent of dissolution of ZnO in serum-free media also
seems to be lower [4]. Thus, interactions of ZnO as well as
zinc ions with serum have to be investigated. Dissolution of
ZnO also strongly depends on the media composition and
especially the pH value, as Cho et al. [10] demonstrated.
Around 90 % of the ZnO was dissolved in artificial lyso-
somal fluid at a pH of 4.5 after 24 h, whereas no dissolu-
tion in Gamble’s solution (pH 7.4) was observed. Another
aspect of the toxicity of ZnO is the surface charge, typi-
cally expressed as the zeta potential. It has been discussed
that nanoparticles that are positively charged at physio-
logical pH usually penetrate cells more readily than neg-
atively charged particles do [4, 11]. To prove or disprove
such a statement is difficult because zeta potential mea-
surements in toxicological studies are often measured only
in water [4, 12, 13], or it is not clear as to where the
potential was measured [11]. So far, only one study on
characterization of the zeta potential of ZnO in various
media has been published [14]. Thus, formerly positively
charged metal/metal oxide NPs were negatively charged as
a result of anionic species in the medium (PBS pH 7.4).
In conclusion, the issue of the toxicity of ZnO
(nano)particles is not fully solved and dispersion media
seems to play a role. Thus, understanding the behavior of
ZnO in cell culture media is a starting point for hazard
assessment. The factors determining the toxicity are
strongly connected to the specific attributes of the tested
organisms and cells. However, examples of in vitro tests
using human cells showed gaps in the understanding of
parameters that control ZnO behavior, dissolution and
hence toxicity. Especially under physiological conditions,
the ZnO behavior, mainly its dissolution, is influenced by
constituents of the cell culture media [15, 16]. With respect
to surface charge and zeta potential and their influence on
the toxicity, several hypotheses have been proposed [4, 11,
14]. It is known that albumin adsorbs onto the ZnO surface,
with consequences for the conformation of the bound
albumin [17]. Further, the protein corona around the par-
ticles has impact on the biological identity of nanomaterials
such as numerous studies show [15, 18, 19]. The link
between protein corona and ZnO, particularly in view of its
solubility should be further investigated. All in all, com-
prehensive characterization of the materials used is nec-
essary for interpretation of toxicological results, as
mentioned in numerous reviews [3, 20–22]. Especially the
behavior of nanoparticles under physiological conditions
must be considered to fully understand the interactions
with components of the culture media [20]. To obtain
meaningful results, a clearly structured procedure in the
dispersion is required.
In the present study, a hydrophilic (ZnO-hydro) and a
lipophilic coated (ZnO-lipo) ZnO powder were studied. A
main aspect of this work was the preparation of stable, i.e.
non-agglomerating stock suspensions for use in in vitro
testing. A two-stage procedure (1, suspension preparation
in non-physiological media; and 2, transferring and testing
in physiological media), as used by many researchers, e.g.,
Bihari et al. [23] and Taurozzi et al. [24], was used. The
proven approach from previous studies [25–28] was
adapted to the requirements of the ZnO powders. The
approach includes the destruction of existing agglomerates
down to the smallest dispersible units of the given powder.
Different dispersing agents were tested to yield an
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optimized stock suspension exhibiting stability over time.
The behavior of ZnO particles under physiological condi-
tions was studied through addition of the stock suspensions
to phosphate buffer (PBS and PBS with BSA) and cell
culture media (DMEM and DMEM/FBS). Extensive
investigations were performed on both the stock suspen-
sions and the particles in DMEM and in DMEM/FBS. For
this purpose, pH, conductivity, particle size, zeta potential,
and dissolved zinc ion concentrations were measured over
several days to record changes in the samples. Finally, the
goal was to record the changes in the kinetics of ZnO as
agglomeration and dissolution under different test condi-
tions in order to improve toxicological studies on ZnO. For
example, it is necessary to know about the actual zinc ion
and zinc oxide concentration in test media, as the basis for
dose–response curves. Last but not least, the Brunauer–
Emmett–Teller (BET) surface area was determined and
particle morphology, aggregation degree, and other prop-
erties were characterized using scanning electron
microscopy.
Methods
ZnO powders and their characterization
The investigations were conducted with ZnO Z-COTE
(abbreviated as ‘‘ZnO-hydro’’) and ZnO Z-COTE HP1
(abbreviated as ‘‘ZnO-lipo’’). Both powders were produced
by BASF SE, Ludwigshafen, Germany, and were provided
by the National Physical Lab, Teddington, UK. The surface
of ZnO-lipo was coated with triethoxycaprylylsilane,
whereas ZnO-hydro was uncoated.
For both powders, specific surface area, crystallinity,
size, and morphology were determined. Nitrogen adsorp-
tion was determined using the BET method with an ASAP
2010 accelerated surface area and porosimetry analyzer
(Micromeritics GmbH, Mo¨nchengladbach, Germany).
Phase compositions were determined by X-ray diffraction
(XRD 7, Seifert-FPM, Germany). Powder imaging was
performed using a Zeiss ULTRA 55 (Carl Zeiss SMT,
Oberkochen, Germany). SEM images of the raw, untreated
powders were first obtained. Then samples were taken from
the suspension for investigation of the deagglomeration
progress after sonication. For this purpose, a small amount
of suspension was filtered through a 50-nm filter, dried, and
analyzed in the SEM.
Zeta potential
The zeta potential was obtained through measurement of
the electrophoretic mobility of the particles using a Zeta-
sizer Nano ZS (Malvern Instruments GmbH, Herrenberg,
Germany). Capillary cells DTS1060C from Malvern
Instruments were used for the electrophoresis measure-
ments. All investigations were performed at 25 C. The
electrophoretic mobility was converted into the Smolu-
chowski zeta potential using the integrated Malvern soft-
ware DTS. For each test, at least ten records were obtained
and then averaged.
Dynamic light scattering (DLS)
Measurements of particle size and size distribution were
performed using a Zetasizer Nano ZS (Malvern Instru-
ments GmbH, Herrenberg, Germany). The device operates
on the principle of DLS, according to which time-depen-
dent fluctuations in the intensity of light scattered from
suspended particles are recorded. The Malvern software
permits different size calculation modes. The cumulant
method described in ISO 22412 yields the mean particle
diameter, xDLS, and the polydispersity index PI. This index
describes the polydispersity of the investigated system (0,
monodisperse; 1, polydisperse). In addition to the cumulant
method, particle size distributions (PSD) were calculated
using the software integrated general purpose mode. A
refractive index of 2.0 was taken for calculation of the PSD
[29]. Due to the fast agglomeration process under physio-
logical conditions found in some cases, the change in
particle size in the physiological media was only evaluated
by the cumulant method. All size measurements were
performed at 25 C.
Suspension preparation
All suspensions were prepared in pure water (resistivity
C18 MX cm; Wilhelm Werner GmbH, Leverkusen, Ger-
many). For uncoated ZnO-hydro, the zeta potential was
recorded as a function of pH. For this purpose, a suspension
of 100 lg/ml with a 1 mM KNO3 background was pre-
pared by sonication for three minutes with 80 % amplitude
(Disintegrator UDS 751 equipped with a 14 mm titanium
probe tip, Topas GmbH, Dresden, Germany). Using this tip
and an amplitude of 80 % results in a theoretical power of
around 130 W. The pH value was adjusted with KOH or
HNO3 of differing molarity (both Merck, Darmstadt, Ger-
many). Due to the low absolute values of the zeta potential
in the measured pH range, no stable suspension could be
achieved by pH adjustment. Suspensions were prepared
using phosphate ions as a dispersing agent. The phosphate
salts used are based on physiological PBS, which consists
of two salts with total 12 mM PO4. Pure water with 10 mM
Na2HPO412H2O (Fluka Analytical, Sigma-Aldrich Che-
mie GmbH, Steinheim, Germany) and 2 mM KH2PO4
(Carl Roth GmbH & Co. KG, Karlsruhe, Germany) were
taken without the addition of NaCl and KCl, both also
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found in physiological PBS. The pH was then adjusted to
7.4 using 1 M HCl (Merck, Darmstadt, Germany). Because
the salt concentration had to remain low for stability rea-
sons, the final stock suspensions contained only a tenth of
this solution (=1.2 mM phosphate). In other words, 0.19
PBS without KCl and NaCl was taken. Furthermore, some
suspensions included the addition of 100 lg/ml soy lecithin
(BDH Prolabo, VWR International GmbH, Darmstadt,
Germany). Lecithin acted as a wetting agent for ZnO-lipo.
For comparison with ZnO-lipo, ZnO-hydro suspensions
with phosphate and lecithin were also prepared and
examined. All nanoparticle suspensions (500 lg/ml ZnO)
were prepared by sonication using the ultrasonic disinte-
grator UDS 751 (14 mm probe tip, 80 % amplitude). For
all suspensions a dispersion time of 4 min was taken. Pre-
investigations monitored with DLS showed that longer
sonication times did not result in a further deagglomeration
progress. To avoid an excessive heating of the particles
during the sonication process the suspensions were placed
in an ice bath. The long-time behavior of stock suspensions
was examined over a period of 14 days, with size param-
eters (xDLS and PI), zeta potential, pH value, conductivity,
and dissolution behavior being recorded. For analysis of
the influence of phosphate and lecithin on ZnO, additional
ZnO-hydro suspensions with just water were prepared. Due
to the instability in pure water, particle size could not be
examined in this case.
Behavior in physiological media
Investigations on the nanoparticle behavior under physio-
logical conditions were performed according to our estab-
lished step-by-step procedure [25–28]. For the
measurements, 10 % (v/v) nanoparticle stock suspension
was added to 90 % (v/v) physiological media. For inves-
tigations at different concentrations, stock suspensions
were diluted with background solution (1.2 mM phosphate
or 1.2 mM phosphate with 100 lg/ml lecithin). The
physiological media used were PBS with calcium and
magnesia (PAA Laboratories GmbH, Pasching, Austria),
DMEM high glucose with pyruvate and L-glutamine
(Invitrogen GmbH, Karlsruhe, Germany), and DMEM
supplemented with 2 % (v/v) or 10 % (v/v) FBS (Bio-
chrom, Berlin, Germany). The particle size and the zeta
potential were measured with the Zetasizer Nano ZS, as
described above.
Dissolution experiments
For analysis of the dissolution behavior of ZnO-hydro,
suspensions containing just water, 1.2 mM phosphate, or
1.2 mM phosphate with 100 lg/ml lecithin were prepared.
For coated ZnO-lipo, only suspensions with 1.2 mM
phosphate and 100 lg/ml lecithin were prepared. Dissolu-
tion of ZnO-hydro and ZnO-lipo was quantified through
measurement of the concentration of free zinc ions after a
defined suspension aging time. For that, samples were
stored at room temperature. First, the suspension was
centrifuged twice at 15,000g for 20 min in a Sigma 4K15
centrifuge (Sigma Laborzentrifugen GmbH, Osterode,
Germany). Next, the clear supernatant was drawn off, and
the zinc concentration was determined using an Ultima
ICP-OES (Horiba Jobin Yvon GmbH, Unterhaching, Ger-
many). Dissolution experiments were performed with ZnO
stock suspensions as well as with ZnO in DMEM and in
DMEM with 10 % FBS.
Results
Powder analysis
ZnO-hydro and ZnO-lipo were very similar in terms of
specific surface and appearance, as visualized by electron
microscopy (Fig. 1). The specific surface area of ZnO-lipo
(14.5 m2/g) was slightly larger than that of ZnO-hydro
(11.7 m2/g). Both powders consisted of agglomerates or
aggregates several micrometers in diameter. SEM images
also showed fine-structured particles within the agglomer-
ates. To describe the aggregation degree of the primary
particles, a deagglomeration step was required (see below).
XRD analysis of both ZnO powders gave the same results,
namely, the presence of a ZnO phase only.
Preparation of NP stock suspension
One way to prepare a stable suspension is to adjust the pH
to regions with high electrostatic repulsive forces between
the particles. Therefore, the zeta potential of ZnO-hydro
was determined as a function of pH (Fig. 2). Dispersion of
the ZnO-hydro suspension resulted in a self-adjusting pH
of 8 and a zeta potential of 28 mV. This value was slightly
below the threshold of 30 mV, which is considered as the
minimum zeta potential for electrostatically stabilized
suspensions [30]. Lowering the pH increased the zeta
potential, but the pH was instable and drifted back to the
initial pH value of 8. Additionally, ZnO dissolved very
well under acidic conditions, inhibiting zeta potential
measurement at pH values of \7. Titration to alkaline
conditions was possible, but after the isoelectric point was
passed at a pH of *10 the zeta potential did not fall below
the critical -30 mV. Higher electrostatic repulsion forces
between the particles were obtained through use of phos-
phate salts as dispersing agents. One advantage of phos-
phates is that they are an integral part of physiological
media. As a result, a zeta potential of *-50 mV for ZnO-
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hydro in just 1.2 mM phosphate background was obtained.
For ZnO-lipo, the nontoxic lecithin was used as a wetting
agent. When only soy lecithin was used, the zeta potential
was -23 mV, which is too low for electrostatic stabiliza-
tion. Suspensions prepared with lecithin and phosphate also
had a zeta potential of &-50 mV. Although lecithin was
not necessary for uncoated ZnO-hydro, suspensions with
lecithin and phosphate were prepared for comparison pur-
poses. They also yielded a zeta potential of around
-50 mV. Four minutes of probe sonication were identified
as the time beyond which no further reduction of the par-
ticle size for both materials occurs. Once optimum dis-
persing conditions were found, stable suspensions could be
prepared by sonication. Table 1 gives the mean particle
size xDLS and polydispersity index PI. There were no
marked differences in size between ZnO-hydro and ZnO-
lipo. The hydrodynamic diameter and the PI of ZnO-hydro
in the suspension with soy lecithin and phosphate were
slightly higher than those of the ZnO-hydro suspension
without lecithin. Thus, the increased size parameters indi-
cated adsorption of lecithin onto the surfaces of the
nanoparticles.
Long-time behavior of stock suspensions
Before ZnO from the stable stock suspension was brought
into contact with the physiological media, the long-time
behavior of the stock suspensions was studied. For
uncoated ZnO-hydro, three types of suspensions were
prepared: (1) in water, (2) in 1.2 mM phosphate, and (3) in
1.2 mM phosphate with 100 lg/ml lecithin. Figure 3
shows the changes in pH, conductivity, zeta potential, and
particle size occurring over a period of 14 days (Fig. 3a).
All suspensions containing phosphate showed an increase
in pH from 7.4 into a more alkaline region. The strongest
increase of up to pH 9 was exhibited by ZnO-hydro sus-
pensions with phosphate and phosphate/lecithin. In con-
trast, the pH of ZnO-hydro in pure water shifted from 7.9 to
7.4 over the 14-day period. As expected, the conductivity
was higher in suspensions with phosphate and phosphate/
lecithin than for ZnO-hydro in pure water (Fig. 3b). In all
cases, the conductivity was found to increase slightly at the
beginning of the experiment before reaching a constant
value. The zeta potential of ZnO-hydro in water had values
between 20 and 28 mV, too low for electrostatic stabil-
ization of the suspensions (Fig. 3c). Hence, useful size
Fig. 1 SEM analysis of ZnO-hydro and ZnO-lipo powders. SEM images of ZnO-hydro (a) and ZnO-lipo (b) at a magnification of 920,000. Both
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Fig. 2 Zeta potential of ZnO-hydro as a function of pH in 1 mM
KNO3. For preparing the suspensions, a background solution of 1 mM
KNO3 was used. Adjustment of pH was done by adding KOH or
HNO3 of differing molarity
Table 1 Size parameters of ZnO-hydro and ZnO-lipo suspensions
Particle (suspension background) xDLS (nm) PI
ZnO-hydro (phosphate) 234 ± 7 0.177 ± 0.065
ZnO-hydro (lecithin and phosphate) 257 ± 6 0.240 ± 0.030
ZnO-lipo (lecithin and phosphate) 224 ± 4 0.142 ± 0.047
The particle size was measured by means of DLS. Suspensions were
prepared at a concentration of 500 lg/ml with sonication. Values are
given as mean ± standard deviation values
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measurements could not be performed by means of DLS.
All suspensions containing 1.2 mM phosphate had negative
zeta potential values due to the adsorbing phosphate ions.
Values were between -50 and -40 mV, sufficient for
electrostatic suspension stabilization. The electrostatic
stabilization of the particles was reflected in a constant
particle size for ZnO-hydro and ZnO-lipo over the whole
time (Fig. 3d). The xDLS was *250 nm for all types of
suspension. Slight variations in size were found only for
ZnO-hydro with phosphate/lecithin.
The results of the dissolution experiments exhibited a
significant difference in the dissolved ZnO quantity
between ZnO particles in water and those in phosphate-
containing suspensions (Fig. 4). For ZnO-hydro in water,
the amount of dissolved zinc was found to be 3.5–4.3 lg/
ml. With the concentration of the stock suspension
(500 lg/ml ZnO) being taken into account, the amount of
ZnO dissolved in pure water was determined to be around
1 % of the total particle mass. Interestingly, the amount of
ZnO dissolved in the suspension with phosphate and leci-
thin was \0.3 %. For ZnO-hydro in the phosphate-
containing suspension without lecithin, zinc concentrations
with a dissolved amount below 0.01 % were measured.
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ZnO-lipo with phosphate and lecithin
Fig. 3 Long-time behavior of ZnO-hydro and ZnO-lipo stock
suspensions over a period of 14 days. a pH, b conductivity, c zeta
potential, and d mean particle diameter xDLS. Size measurements
(DLS) were performed after dilution to a concentration of 50 lg/ml.
Dilution of the stock suspensions was done with the appropriate
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ZnO-hydro with phosphate and lecithin ZnO-lipo with phosphate and lecithin
Fig. 4 Dissolution of ZnO-hydro and ZnO-lipo as a function of
suspension composition. Suspensions were centrifuged twice for
separating particles from dissolved components. The zinc concentra-
tion of the clear supernatant was then analyzed using an ICP-OES
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significant increase in the amount of zinc oxide dissolved
was observed over time.
SEM images of ZnO-hydro and ZnO-lipo particles in
stock suspensions showed primary particles with sizes of
around 200 nm and below (Fig. 5). In many cases, they
were connected to larger aggregates. Arrangements of the
single particles were more difficult to recognize in the
coated ZnO-lipo than in the uncoated ZnO-hydro. Inter-
estingly, cubic particles with an edge length of around
1 lm were found for the ZnO-hydro sample in 1.2 mM
phosphate. EDX analysis revealed that these cubic particles
had a different composition from that of the ZnO particles
(Fig. 5a). In the case of the ZnO particles, the zinc and
oxygen peaks had the highest intensities in the EDX
spectrum. Determination of the quantity of every elemental
peak yielded 75 % (w/w) zinc and 24 % (w/w) oxygen, in
good agreement with the theoretical values for ZnO of
80 % zinc (w/w) and 20 % (w/w) oxygen. In contrast, the
EDX spectrum of the cubic particles showed characteristic
peaks for C, O, Zn, and P. The high intensity of the carbon
peak was surely a contribution of the filter and not of the
cubic particles. With the carbon peak omitted, the fol-
lowing weight concentrations were found: 43 % (w/w)
oxygen, 47 % (w/w) zinc, and 10 % (w/w) phosphor. ZnO-
hydro and ZnO-lipo in suspensions with phosphate and
lecithin exhibited ZnO particles only.
Behavior under physiological conditions
After the stock suspension was added to the physiological
media, the particle sizes of ZnO-hydro and ZnO-lipo were
recorded by means of DLS. Figure 6 shows the changes in
particle size over time on the basis of the xDLS at a ZnO
concentration of 50 lg/ml. The measurements revealed
that ZnO-hydro particles from the stock suspension with
1.2 mM phosphate agglomerated after being added to PBS.
In contrast, ZnO-hydro and ZnO-lipo particles from sam-
ples in 1.2 mM phosphate with lecithin remained stable in
PBS. The same experiments were performed in DMEM to
reveal possible differences due to the different composi-
tions of DMEM and PBS. Again, particles from suspen-
sions with lecithin retained their initial size, whereas ZnO-
hydro particles without lecithin agglomerated (data not
shown). The only difference was that ZnO-hydro particles
without lecithin agglomerated faster in PBS than in
DMEM. For precise quantification of the differences in
behavior of ZnO-hydro without lecithin in PBS and in
DMEM, studies were conducted at a concentration of
10 lg/ml. Agglomeration was slower at 10 than at 50 lg/
ml (Fig. 7). Additionally, the assumption of faster
agglomeration in PBS was confirmed at a concentration of
10 lg/ml. Samples with ZnO-hydro and ZnO-lipo con-
taining lecithin did not agglomerate in PBS or DMEM at a
particle concentration of 10 lg/ml either (data not shown).
Fig. 5 SEM images of ZnO-hydro and ZnO-lipo prepared from
suspension. a ZnO-hydro taken from a suspension containing 1.2 mM
phosphate and b ZnO-lipo taken from a suspension containing
1.2 mM phosphate and 100 lg/ml lecithin. Both samples were filtered


























ZnO-hydro (stock suspension with 1.2 mM phosphate)
ZnO-hydro (stock suspension with 1.2 mM phosphate + lecithin)
ZnO-lipo (stock suspension with 1.2 mM phosphate + lecithin)
Fig. 6 Behavior of ZnO-hydro and ZnO-lipo particles after addition
to PBS. The particle concentration after combination of the stock
suspension with PBS was 50 lg/ml. The legend shows the back-
ground of the stock suspension used
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Further experiments were performed on DMEM sup-
plemented with 2 or 10 % serum (FBS). Due to the fact
that lecithin-containing ZnO-hydro and ZnO-lipo samples
showed no differences in terms of their behavior in PBS
and in DMEM, investigations in DMEM with serum were
limited to stock suspensions with ZnO-hydro in phosphate
and ZnO-lipo in phosphate/lecithin. Figure 8 shows xDLS of
ZnO-hydro and ZnO-lipo in DMEM supplemented with 2
or 10 % FBS over a period of 3 days. For ZnO-lipo in
DMEM with 2 % FBS, the particle size remained constant
within the first 24 h, after which time the size increased
slightly, finally reaching a xDLS of around 350 nm after
3 days. In contrast, the particle size of ZnO-lipo in DMEM
with 10 % FBS remained constant, even decreasing
slightly. The uncoated ZnO-hydro particles did not
agglomerate in DMEM with 2 % FBS or in DMEM with
10 % FBS. Furthermore, the mean size eventually dropped
below the initial value.
Besides size measurements, the zeta potentials in PBS,
DMEM, and DMEM supplemented with FBS were recor-
ded (Table 2). After the stock suspensions were added to
the physiological media, the zeta potential increased from
*-50 mV to values above -30 mV, considered to be the
stability threshold [30]. In DMEM with FBS, zeta potential
values were between -8.7 and -10.4 mV, similar to that
in ZnO-free DMEM with FBS (around -8 mV). The
polydispersity of all tested samples was increased in
DMEM with FBS (PI from 0.2 to 0.4) as compared to
values of the stock suspension (Table 1). When using the
general purpose mode, in some cases, a peak of protein in
addition to the actual peak of particles were detected at the
same time.
The extent of dissolution of ZnO was higher in DMEM
and DMEM supplemented with FBS than in the stock

























ZnO-hydro in PBS 50 µg/ml ZnO-hydro in PBS 10 µg/ml
ZnO-hydro in DMEM 50 µg/ml ZnO-hydro in DMEM 10 µg/ml
Fig. 7 Agglomeration behavior of ZnO-hydro particles after addition
to PBS and DMEM. The particle concentrations after combination of
the stock suspension with PBS and DMEM were 50 and 10 lg/ml,



























ZnO-hydro in DMEM + 2% FBS ZnO-hydro in DMEM + 10% FBS
ZnO-lipo in DMEM + 2% FBS ZnO-lipo in DMEM + 10% FBS
Fig. 8 Particle sizes of ZnO-hydro and ZnO-lipo in DMEM with
FBS over a period of 3 days. The particle concentration was 50 lg/
ml. A ZnO-hydro stock suspension with 1.2 mM phosphate and a
ZnO-lipo stock suspension with 1.2 mM phosphate and lecithin were
used
Table 2 Zeta potential in mV of ZnO-hydro and ZnO-lipo in PBS,
DMEM, and DMEM supplemented with FBS






-16.2 ± 1.2 -7.4 ± 1.4 -8.7 ± 1.3 -9.2 ± 0.9
ZnO-
lipo
-24.3 ± 2.7 -21.7 ± 2.6 -10.4 ± 1.2 -9.1 ± 1.1
The particle concentration in physiological media was 50 lg/ml. The
stock suspensions used were ZnO-hydro in 1.2 mM phosphate and
ZnO-lipo in 1.2 mM phosphate with lecithin. Zeta potential values are






























DMEM + serum (ZnO-hydro)
DMEM + serum (ZnO-lipo)
Fig. 9 Dissolution behavior of ZnO-hydro and ZnO-lipo in DMEM
with or without FBS over a period of 3 days. The particle
concentration was 50 lg/ml. A ZnO-hydro stock suspension with
1.2 mM phosphate and a ZnO-lipo stock suspension with 1.2 mM
phosphate and lecithin were used
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physiological media was only a tenth of those in the stock
suspensions (Fig. 9). Furthermore, the extent of dissolution
of ZnO-hydro and ZnO-lipo was higher in the presence of
serum, and the process in serum-containing media seemed
to be material-independent. In serum-free DMEM, ZnO-
hydro dissolved better than coated ZnO-lipo did.
Discussion
One aim of the present study was to prepare stable stock
suspensions from a hydrophilic and a lipophilic ZnO
powder as a prerequisite for performing toxicological
in vitro testing. Investigations were also carried out in
different physiological fluids to improve the understanding
and interpretation of the results of toxicological experi-
ments. For this purpose, the ZnO-containing stock sus-
pensions were combined with the physiological fluids such
as was previously done in numerous other studies [25–28].
Phosphate salts are suitable for electrostatic suspension
stabilization
Besides the preparation and characterization of the sus-
pension, comprehensive powder characterization is essen-
tial for further investigations [20]. Concerning their powder
properties, hydrophilic ZnO-hydro and hydrophobic ZnO-
lipo were very similar. This was not surprising because
they both consisted of the same initial powder, but ZnO-
lipo was coated with triethoxycaprylylsilane. Both powders
consisted of micrometer-sized agglomerates with submi-
cron- and nanometer-sized primary particles. After soni-
cation the agglomerates could be broken up into smaller
particles with a mean size xDLS of around 250 nm. For use
in toxicological experiments, the particles of the stock
suspension must be stable over time and may not
agglomerate. One stabilization mechanism is based on the
electrostatic repulsion of the particles. A simple method of
achieving this is through adjustment of the pH to regions
with high absolute values of the zeta potential. For ZnO-
hydro, a pH below 7.5 is suitable, but if the original pH of 8
is decreased to lower values, the dissolution tendency
increases. Thus, lowering of the pH by addition of acid was
not useable in this case. Instead, phosphate salts, which are
main components of nearly all physiological media and
hence biocompatible, were added. The phosphate salts used
were chosen to have suspensions with a physiological pH
of 7.4. Further phosphates and polyphosphates are known
to act as dispersants [31, 32]. Due to the use of phosphates,
zeta potential values of around –50 mV were obtained.
This resulted in good electrostatic stabilization of the sus-
pension, as clearly demonstrated by the constant particle
size values.
Lecithin can be used as a biocompatible wetting agent
for hydrophobic powders
For lipophilic ZnO-lipo, a wetting agent is a prerequisite
for particle suspension. In this study, soy lecithin was taken
as a wetting agent. Lecithins are phospholipids, which
include, e.g., the surfactant constituent dipalmitoylpho-
sphatidylcholine (DPPC). Several studies showed that
DPPC is an excellent and nontoxic dispersant [33, 34].
Preparation of ZnO-lipo suspension with only lecithin had
a zeta potential of –23 mV, which was not sufficient for
electrostatic stabilization. Additional phosphate shifted the
zeta potential of ZnO-lipo to values of &-50 mV. Fur-
thermore, no differences in zeta potential compared with
ZnO-hydro in 1.2 mM phosphate and those in 1.2 mM
phosphate with lecithin were found. Therefore, the domi-
nating component for electrostatic stabilization of the
suspension was concluded to be phosphate.
Suspensions exhibit long-time stability, but complex
dissolution processes occur
The two different ZnO-hydro stock suspensions and the
ZnO-lipo stock suspension remained stable over the test
period of 14 days, as demonstrated by the constant mean
particle size of around 250 nm. Due to the use of different
ZnO-hydro suspension types, the influence of the various
additives could be studied well. In water, suspended ZnO-
hydro particles were not stable and agglomerated as a
result of the low electrostatic repulsion forces. Remark-
ably, the extent of dissolution in water was low
(3.5–4.3 lg/ml zinc), corresponding to just 1 % ZnO. The
values were in good agreement with those reported by
Dimkpa and colleagues [35]. His investigations were
performed at an identical ZnO concentration and resulted
in 4.9 lg/ml (ZnO NP) and 4.6 lg/ml (ZnO Bulk) of
dissolved zinc at a pH of 7. Dissolution in water was
much higher compared with ZnO-hydro in phosphate with
lecithin (0.3 %) and with ZnO-hydro in phosphate
(0.03 %). At first glance, it was not immediately apparent
as to why the dissolution of ZnO-hydro in the phosphate-
containing media was lower. Another unclear aspect was
the influence of lecithin, since dissolution of ZnO
increased further in the presence of this wetting agent. It
was supposed that the measured zinc concentration in the
supernatant of phosphate- and phosphate/lecithin-contain-
ing samples did not represent the real amount of dissolved
ZnO particles. Proof of a greater extent of ZnO dissolution
was given by the pH increase from 7.4 to 9. Although
phosphate had pH-buffering properties, the pH value
increased notably, reflecting the release of numer-
ous hydroxide ions according to the equation
ZnO ? H2O ? Zn
2? ? 2 OH- [36].
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Furthermore, SEM analysis of particles obtained from
the phosphate-containing ZnO-hydro suspension without
lecithin revealed cubic particles with an edge length of
*1 lm. These cubic particles consisted of about equal
mass fractions of Zn and O and also contained 10 % P, as
shown by the EDX analysis. Thus, the formed crystals
corresponded to a zinc phosphate compound. Conse-
quently, the phosphate ions in the suspensions were con-
sumed by both the released hydroxyl ions and the resulting
zinc phosphate compound. Hence, not enough phosphate
ions were available to act as pH buffers. Dissolution
equilibrium was presumably reached when the pH stopped
increasing. In contrast to these findings, Michelmore et al.
[37] described the reaction of solid ZnO with water and
phosphate ions to form a hydroxyphosphato complex
according to the equation ZnO ? H2O ? HPO4
2- /
? Zn(OH)2(HPO4)
2-. In Michelmore’s study, investiga-
tions with ZnO and polyphosphate yielded zinc polyphos-
phate complexes that precipitated on the ZnO surfaces.
They further found that the concentration of dissolved zinc
increases with increasing polyphosphate concentration. It is
therefore conceivable that similar processes can even occur
when simple phosphate is used. If such complexes of zinc
and phosphate were formed and were bound to the particle
surface, they would be separated during centrifugation.
Consequently, the measured zinc concentration in the
supernatant would be less than expected. Another aspect,
described for TiO2, is that surface hydroxyl groups can be
exchanged with phosphate ions [38]. The same substitution
might occur on the ZnO surface.
Remarkably, the cubic zinc phosphate crystals were only
found for ZnO-hydro suspensions in 1.2 mM phosphate. For
ZnO-hydro and ZnO-lipo suspensions with phosphate and
soy lecithin, such crystals were absent. In the case of the
uncoated ZnO-hydro, the two suspensions differed only in
terms of the presence or absence of lecithin. Due to the fact
that lecithins are phospholipids, their phosphate group could
bind the dissolved zinc ions as well. If binding of zinc ions to
lecithin occurred preferentially, no or a smaller amount of
zinc phosphate compound would precipitate. The assump-
tion that the dissolved zinc ions were bound to lecithin was
supported by the higher zinc concentrations measured in the
centrifugal supernatant. The ZnO particles as well as the
1-lm cubic zinc phosphate crystals could be separated from
the dissolved zinc ions by centrifugation, but the zinc-loaded
lecithin could not be separated. The molecular weight was
too small to be affected by the centrifugal forces.
Stock suspensions with phosphate and lecithin can be
used for reproducible toxicological experiments
Finally, suspensions with deagglomerated, stabilized ZnO
particles are available, but the addition of dispersant is
necessary. Phosphate and lecithin are biocompatible and
effective dispersants in terms of electrostatic stabilization
and wetting, respectively. Both dispersants affect the
behavior of the suspended ZnO particles, especially the
dissolution. Because phosphate is generally present in
physiological environments and phospholipids are essential
components of surfactants, reactions taking place in the
stock suspension would proceed naturally later on in a
physiological surrounding. The advantage of the present
method is that these reactions have already been com-
pleted, and constant conditions for further investigation,
e.g., in toxicological studies, are therefore given.
Lecithin and serum proteins inhibit particle
agglomeration in physiological media
For the addition of stabilized ZnO-hydro particles to
physiological media, stock suspensions with phosphate
were a prerequisite, whereas ZnO-lipo particles required
the addition of lecithin as a wetting agent. In protein-free
physiological media, the particle behavior depended on the
presence of lecithin in the stock suspension. ZnO-hydro
particles previously stabilized with phosphate agglomer-
ated in PBS and DMEM. As expected, the agglomeration
velocity increased with increasing particle concentration.
More particles in the same volume meant an increased
probability of particle–particle contact. These findings
were in agreement with studies on other particles in
physiological media [25, 26, 39] as well as in media used
for ecotoxicological purposes [40]. Electrostatic repulsion
forces were lower in physiological media due to the high
electrolyte content, demonstrated by the low absolute val-
ues of the zeta potential. The values were outside the sta-
bility range of \-30 mV or greater ?30 mV [30].
However, ZnO-hydro without added lecithin had a negative
zeta potential in both PBS (-16.2 mV) and DMEM
(-7.4 mV), verifying the statement of Cho et al. [14] that
ZnO is negatively charged in physiological media. Thus,
ZnO and other metal oxide NPs should not simply be
regarded as positively charged NPs, as has been done in
other studies based on the positive zeta potential value in
water [4, 12, 13]. Especially for PBS, it can be concluded
that the adsorbed phosphate ions were responsible for the
negative charge. The only other negatively charged ion in
PBS was chloride, which is not known to have a high
adsorbing ability, in contrast to phosphate, which is known
as a strongly adsorbing species [41]. In contrast, DMEM is
a very complex media, making an attribution to one
adsorbing species difficult. Adsorbed phosphate ions pre-
sumably codetermine the surface charge of ZnO. Interest-
ingly, the zeta potential was significantly less negative in
PBS than in DMEM. This also confirmed the domination of
adsorbed phosphate in PBS.
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ZnO particles, whether coated or not, did not agglom-
erate in physiological fluids when the stock suspensions
previously contained lecithin. The particles remained the
initial size of the stock suspension in PBS and DMEM even
though the zeta potentials were outside the stable region.
Therefore, the mechanism of stabilization had to be sterical
or electrosterical. This can only be explained by the fact
that lecithin was adsorbed on the particle surface, and thus
the particles were stabilized. Other studies also described a
stabilizing effect of lecithin and DPPC [33, 34, 42].
In DMEM supplemented with FBS, agglomeration of
ZnO-hydro and ZnO-lipo particles was inhibited through
the presence of serum proteins. The ZnO-hydro particles
without lecithin in the stock suspension also remained
stable, eliminating the need for lecithin as a stabilizing
agent in protein-containing media. The findings confirmed
the results of our own studies [25–28] and those of other
groups [23, 39, 43] that proteins, especially BSA, stabilize
different kinds of nanoparticles under physiological con-
ditions. Furthermore, Tantra et al. [44] were able to dem-
onstrate a stabilizing effect of BSA for ZnO particles, but
these investigations were carried out in deionized water
and not in physiological media.
Stabilization of particles through serum depends on the
amount of available proteins. The particle size of ZnO-lipo
increased slightly in DMEM with only 2 % FBS, whereas
10 % FBS permitted full stabilization over 3 days. For
ZnO-hydro, no differences due to the different FBS quan-
tities were found. Furthermore, protein adsorption and the
related stabilization mechanisms strongly depend on the
particle’s hydrophilicity and hydrophobicity, respectively.
This, in turn, could possibly suggest the formation of other
adsorption layers. The slight decrease in the mean particle
size xDLS of ZnO-hydro and ZnO-lipo (DMEM with 10 %
FBS) below values obtained in stock suspensions could not
be indicative of further progression of deagglomeration
because the stock suspension contained indestructible
aggregates. The size decrease must have resulted from
sedimentation of the ZnO particles within the investigation
period of 3 days. In all samples tested, an increased PI was
observed that is certainly a consequence of the parallel
presence of particles and proteins. The cumulant analysis is
restricted in this case as it only yields an average particle
diameter and no multiple peaks. A particle and protein
peak were monitored using the general purpose mode, but
this complex analysis model tends to have stronger devi-
ations. All in all, DLS is limited in these complex fluids.
The zeta potential of ZnO in DMEM with FBS was
between -8.7 and -10.4 mV regardless of the FBS
amount and the ZnO particles used. This conformity sug-
gests that serum proteins adsorbed onto the particle surface,
with the result that protein-coated ZnO particles appeared
electrostatically to be like the free serum proteins. Such
zeta potential values of protein-covered particles in phys-
iological media are often found and seem to be particle-
independent [23, 45, 46].
The increased dissolution in DMEM and DMEM/FBS
compared with the stock suspension could possibly have
been caused by the high electrolyte content in the physio-
logical media. In the presence of serum, an additional
increase in dissolution was detected, confirming Hsiao’s
and Huang [4] finding that more ions are released in media
with serum than in media without serum. This seems to be
a general fact, because SiO2 also showed a higher disso-
lution under biological media conditions as compared to
water alone [47]. According to Nel et al. [15], two mech-
anisms explain the increased dissolution of ZnO and other
nanomaterials due to the protein availability. Free ions
released from the material’s surface form complexes with
proteins. Organic material can also extract surface metal
atoms from the nanoparticle surface. In Xia’s work [6], the
maximum total dissolved zinc concentration in DMEM
with FBS was 225 lM, or 14.7 lg/ml Zn2?, in the range of
our dissolved zinc measurements of 13.4 lg/ml (=3.4 %
dissolved ZnO) to 20.0 lg/ml (=5.0 % dissolved ZnO).
This match could be an indication of a saturation concen-
tration of dissolved zinc in a cell culture medium supple-
mented with serum.
Conclusions
In this study, a feasible method for preparing stable, non-
physiological suspensions containing hydrophilic or lipo-
philic ZnO particles was developed. Because stabilization
via pH adjustment was not possible, phosphate was taken
as a dispersant and lecithin as a wetting agent for the
lipophilic ZnO. The resulting suspensions showed constant
values with respect to particle size and zeta potential over a
test period of 14 days, thus meeting a prerequisite for
further toxicological studies. However, reactions occurred
between ZnO and the phosphate ions, in turn affecting the
dissolution of the powders. Although these reactions took
place in a non-physiological fluid, they nevertheless yiel-
ded conclusions about the influence of complex cell culture
media, which always contain phosphate ions. ZnO under-
went extensive dissolution, detected not directly through
the zinc ion concentration but rather through the pH, which
showed an increase. The dissolved zinc ions formed com-
plexes with phosphate and lecithin, which contained a
phosphate group in its molecular structure.
In physiological media with higher electrolyte contents
and more phosphate ions, the extent of dissolution of ZnO
increased. Additional serum increased the dissolution rate
even further. Different additives clearly had different
effects on the stability of ZnO particles in physiological
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media. Phosphate-stabilized ZnO particles were found to
agglomerate in PBS and DMEM in a process depending on
the mass concentration and the physiological media. In
comparison, ZnO particles suspended in water with phos-
phate/lecithin did not agglomerate after being added to
physiological media. It is believed that lecithin adsorbs on
the particle surface, thereby effecting sterical or electros-
terical stabilization. In the presence of serum in the media,
particle agglomeration was effectively prevented regardless
of the stabilization variants of the stock suspension (phos-
phate or phosphate/lecithin). The protein adsorption was
reflected in a shift in the zeta potential to about -10 mV,
corresponding to the value for the free serum proteins.
In summary, the approach described here allows for the
preparation of non-agglomerating, well-characterized ZnO
suspensions with particles that are dispersed to the smallest
achievable dimension. This is a prerequisite for the use in
in vitro testing. Furthermore, comprehensive time-depen-
dent characterization of particle behavior under non-phys-
iological as well as physiological conditions gave better
insight into the dissolution properties of ZnO, which can be
useful for interpretation of the results of toxicological
studies of ZnO (nano)particles. This allows the correlation
between the chemical-physical particles behavior with
findings from toxicological tests.
For ecotoxicological assessment of ZnO and other
nanomaterials, our approach has to be adapted despite
media in ecotoxicological tests differ in their composition
compared with cell culture media. Phosphate is undesirable
in many cases for use in ecotoxicological media and free
proteins are not available either. But also the environment
has lots of dispersants, e.g. humic substances that are
suitable for the stabilization of nanomaterials.
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